clinmedКлиническая медицинаClinical Medicine (Russian Journal)0023-21492412-1339ООО «Медицинское информационное агентство»10.30629/0023-2149-2020-98-6-405-413clinmed-75Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESСвертываемость крови при коронавирусной инфекционной болезни: анализ проблемы и наше мнениеHemocoagulation in coronavirus viral disease: analyses of the problem and our opinionhttps://orcid.org/0000-0001-5331-2655БокаревИ. Н.BokarevI. N.https://orcid.org/0000-0002-3496-6466ПоповаЛ. В.PopovaL. V.

Попова Людмила Викторовна — кандидат медицинских наук, доцент кафедры госпитальной терапии №1 Института клинической медицины им. Н.В. Склифосовского

119991, Москва

Lyudmila V. Popovа — MD, PhD, associate Professor of the Department of hospital therapy No. 1 Of the Institute of clinical medicine

119991, Moscow

mila_foka@mail.ruВсероссийская ассоциация по изучению тромбозов, геморрагий и патологии сосудов им. А.А. Шмидта–Б.А. КудряшоваРоссияRussian Association for the Study of Thrombosis, Hemorrhages and Vascular Pathology named after A.A. Schmidt–B.A. KudryashovaRussian FederationВсероссийская ассоциация по изучению тромбозов, геморрагий и патологии сосудов им. А.А. Шмидта–Б.А. Кудряшова; ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет)РоссияRussian Association for the Study of Thrombosis, Hemorrhages and Vascular Pathology named after A.A. Schmidt–B.A. Kudryashova; First Moscow State Medical University of the Ministry of Health of the Russian Federation named after Sechenov I.M. (Sechenov University)Russian Federation202025112020986405413Copyright © Бокарев И.Н., Попова Л.В., 20202020Бокарев И.Н., Попова Л.В.Bokarev I.N., Popova L.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.clinmedjournal.com/jour/article/view/75

В статье дается обзор современной последней литературы, посвященной состоянию гемокоагуляции при вирусном заболевании COVID-19, которое вызывается SARS-CoV-2. Рассматриваются вопросы его патогенеза и высказываются предположения о возможной пользе больным от применения лекарственных препаратов, влияющих на тромбоцитарное звено свертывания крови.

The article provides an overview of the recent literature on the state of hemocoagulation in the viral disease COVID-19 caused by SARS-CoV-2. The issues of its pathogenesis are considered and assumptions are made about the possible benefits of patients from the use of medications that affect the platelet units.

COVID-19гемокоагуляциивенозный тромбоэмболизмCOVID-19hemocoagulationvenous thromboembolismReferencesworldometers.info [Электронный ресурс]. URL: https://www.worldometers.info/coronavirus/ (5 jule 2020).worldometers.info [Электронный ресурс]. URL: https://www.worldometers.info/coronavirus/ (5 jule 2020).Robb J.A., Bond C.W. Coronaviridae. Comprehensive Virology. 1979;6:193–247. DOI: 10.1007/978-1-4684-3563-4_3.Worldometers. [Electronic resource]. URL: https://www.worldometers.info/coronavirus/ (5 jule 2020).Communicable disease threats report, 9–15 February 2020, week 7. ECDC (5 jule 2020) [Электронный ресурс]. URL: https://www.ecdc.europa.eu/sites/default/files/documents/communicabledisease-threats-report-15-Feb-2020-PUBLIC.pdf.Robb J.A., Bond C.W. Coronaviridae. Comprehensive Virology. 1979;6:193–247. DOI: 10.1007/978-1-4684-3563-4_3.International Committee on Taxonomy of Viruses ICTV [Электронный ресурс]. URL: https://talk.ictvonline.org/ (5 june 2020).Communicable disease threats report, 9–15 February 2020, week 7. ECDC (5 jule 2020) [Electronic resource]. URL: https://www.ecdc.europa.eu/sites/default/files/documents/communicable-disease-threats-report-15-Feb-2020-PUBLIC.pdf.Beeching N.J., Fletcher T.E., Fowler R. COVID-19. BMJ Best Practices. BMJ Publishing Group (17 февраля 2020).International Committee on Taxonomy of Viruses ICTV [Electronic resource]. URL: https://talk.ictvonline.org/ (5 june 2020).Министерство здравоохранения Российской Федерации [Электронный ресурс]. URL: https://minzdrav.gov.ru.(5 jule 2020)Beeching N.J., Fletcher T.E., Fowler R. COVID-19. BMJ Best Practices. BMJ Publishing Group (17 февраля 2020).Dijkman R., Jebbink M.F., Deijs M, Milewska A., Pyrc K, Buelow E. et al. Replication-dependent downregulation of cellular angiotensin-converting enzyme 2 protein expression by human coronavirus NL63. J. Gen. Virol. 2012;93(9):1924–1929. DOI: 10.1099/vir.0.043919-0.Ministry of health of the Russian Federation [Electronic resource]. URL: https://minzdrav.gov.ru.(5 jule 2020).Li W., Moore M.J., Vasilieva N., Sui J., Wong S. K., Berne M. A., et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426(6965):450–454. DOI: 10.1038/nature02145.Dijkman R., Jebbink M.F., Deijs M, Milewska A., Pyrc K, Buelow E. et al. Replication-dependent downregulation of cellular angiotensin-converting enzyme 2 protein expression by human coronavirus NL63. J. Gen. Virol. 2012;93(9):1924–1929. DOI: 10.1099/vir.0.043919-0.Robb J. What I am doing for the upcoming COVID-19 (coronavirus) pandemic [Электронный ресурс]. http://www.europe-solidaire.org/spip.php?article52289 (5 jule 2020)Li W., Moore M.J., Vasilieva N., Sui J., Wong S. K., Berne M. A., et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426(6965):450–454. DOI: 10.1038/nature02145.Carsana L., Sonzogni A., Nasr A., Rossi R.S., Pellegrinelli A., Zerbi P. et al. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study Lancet. 2020. [Epub ahead of print]. DOI: 10.1016/S14733099(20)30434-5.Robb J. What I am doing for the upcoming COVID-19 (coronavirus) pandemic [Electronic resource]. http://www.europe-solidaire.org/spip.php?article52289 (5 jule 2020)Зайратьянц О.В., Самсонова М.В., Михалева Л.М., Черняев А.Л., Мишнев О.Д., Крупнов Н.М., Калинин Д.В. Патологическая анатомия COVID-19. Атлас. Москва 2020. С 140.Carsana L., Sonzogni A., Nasr A., Rossi R.S., Pellegrinelli A., Zerbi P. et al. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. Lancet. 2020. [Epub ahead of print]. DOI10.1016/S1473-3099(20)30434-5.BTS Guidance on Venous Thromboembolic Disease in patients with COVID-19. Updated 4 May 2020. British Thoracic Society [Электронный ресурс]. URL: https://brit-thoracic.org.uk/documentlibrary/quality-improvement/covid-19/bts-guidance-on-venousthromboembolic-disease-inpatients-with-covid-19/. (5 jule 2020)Zairatyants O.V., Samsonova M.V., Mikhaleva L.M., Chernyaev A.L., Mishnev O.D., Krupnov N.M., Kalinin D.V. Pathological anatomy covid-19. Atlas. Moscow 2020. C 140 (in Russian).Cui S., Chen S., Li X., Liu S., Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J. Thromb. Haemos. 2020;18(6):1421–1424. DOI: 10.1111/jth.14830BTS Guidance on Venous Thromboembolic Disease in patients with COVID-19. Updated 4 May 2020. British Thoracic Society [Electronic resource]. URL: https://brit-thoracic.org.uk/document-library/quality-improvement/covid-19/bts-guidance-on-venous-thromboembolic-disease-inpatients-with-covid-19/. (5 jule 2020)Klok F.A., Kruip M.J.H.A., van der Meer N.J.M., Arbous M.S., Gommers D.A.M.P.J., Kant K.M. et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb. Res. 2020;191:145–147. DOI: 10.1016/j.thromres.2020.04.013.Cui S., Chen S., Li X., Liu S., Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J. Thromb. Haemos. 2020;18(6):1421–1424. DOI: 10.1111/jth.14888.Middeldorp S., Coppens M., van Haaps T.F., Foppen M., Vlaar A.P., Müller M.C.A. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J. Thromb. Haemost. 2020;18(8):1995– 2002. DOI: 10.1111/jth.14888.Klok F.A., Kruip M.J.H.A., van der Meer N.J.M., Arbous M.S., Gommers D.A.M.P.J., Kant K.M. et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb. Res. 2020;191:145–147. DOI: 10.1016/j.thromres.2020.04.013.Helms J., Tacquard C., Severac F., Leonard-Lorant I., Ohana M., Delabranche X. et al. High risk of thrombosis in patients in severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089–1098. DOI: 10.1007/s0013402006062-x.Middeldorp S., Coppens M., van Haaps T.F., Foppen M., Vlaar A.P., Müller M.C.A. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J. Thromb. Haemost. 2020;18(8):1995– 2002. DOI: 10.1111/jth.14888.Grillet F., Behr J., Calame P., Aubry S., Delabrousse E. Acute Pulmonary Embolism Associated with COVID-19 Pneumonia Detected by Pulmonary CT Angiography. Radiology. 2020. [Epub ahead of print] DOI: 10.1148/radiol.2020201544Helms J., Tacquard C., Severac F., Leonard-Lorant I., Ohana M., Delabranche X. et al. High risk of thrombosis in patients in severe SARSCoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089–1098. DOI: 10.1007/s00134-02006062-x.Bompard F., Monnier H., Saab I., Tordjman M., Abdoul H., Fournier L. et al. Pulmonary embolism in patients with Covid-19 pneumonia. Revel. Eur. Respir. J. 2020. [Epub ahead of print]. DOI: 10.1183/13993003.01365-2020.Grillet F., Behr J., Calame P., Aubry S., Delabrousse E. Acute Pulmonary Embolism Associated with COVID-19 Pneumonia Detected by Pulmonary CT Angiography. Radiology. 2020. [Epub ahead of print] DOI: 10.1148/radiol.2020201544Poyiadji N., Cormier P., Patel P.Y., Hadied M.O., Bhargava P., Khanna K. et al. Acute Pulmonary Embolism and COVID-19. Radiol. 2020. [Epub ahead of print]. DOI: 10.1148/radiol.2020201955.Radiology.Bompard F., Monnier H., Saab I., Tordjman M., Abdoul H., Fournier L. et al. Pulmonary embolism in patients with Covid-19 pneumonia. Revel. Eur. Respir. J. 2020. [Epub ahead of print]. DOI: 10.1183/13993003.01365-2020.Lodigiani C., Iapichino G., Carenzo L., Cecconi M., Ferrazzi P., Sebastian T. et al. Humanitas COVID-19 Task Force. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb. Res. 2020;191:9–14. DOI: 10.1016/j.thromres.2020.04.024.Poyiadji N., Cormier P., Patel P.Y., Hadied M.O., Bhargava P., Khanna K. et al. Acute Pulmonary Embolism and COVID-19. Radiol. 2020. [Epub ahead of print]. DOI: 10.1148/radiol.2020201955.Radiology.Wichmann D., Sperhake J.P., Lutgehetmann M., Steurer S., Edler C., Heinemann A. et al. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19. Ann. Intern. Med. 2020;M20– 2003. [Epub ahead of print]. DOI: 10.7326/M20-200320-2003.Lodigiani C., Iapichino G., Carenzo L., Cecconi M., Ferrazzi P., Sebastian T.et al. Humanitas COVID-19 Task Force. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb. Res. 2020;191:9–14. DOI: 10.1016/j.thromres.2020.04.024.Lax S.F., Skok K., Zechner P., Kessler H.H., Kaufmann N., Koelblinger C., et al Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case Series. Ann. Intern. Med. 2020;14:20–2566. [Epub ahead of print]. DOI: 10.7326/M20-2566.Wichmann D., Sperhake J.P., Lutgehetmann M., Steurer S., Edler C., Heinemann A. et al. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19. Ann. Intern. Med. 2020;M20– 2003. [Epub ahead of print]. DOI: 10.7326/M20-200320-2003.Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism. NICE. 2018. [Электронный ресурс]. URL: https://www.nice.org.uk/guidance/ng89 (10 may 2020).Lax S.F., Skok K., Zechner P., Kessler H.H., Kaufmann N., Koelblinger C., et al Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case Series. Ann. Intern. Med. 2020;14:20–2566. [Epub ahead of print]. DOI: 10.7326/M20-2566.Cook D., Crowther M., Meade M., Rabbat C., Griffith L., Schiff D. et al. Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors. Crit. Care Med. 2005; 33(7):1565–1571. DOI: 10.1097/01.CCM.0000171207.95319.B2.Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism. NICE. 2018. [Electronic resource]. URL: https://www.nice.org.uk/guid- ance/ng89 (10 may 2020).Hunt B.J. Preventing Venous Thromboembolism in the Critically Ill — Can We do More? J. Intensive Care Soc. 2014;5(3):3–5. DOI: 10.1177/17511437140151S302.Cook D., Crowther M., Meade M., Rabbat C., Griffith L., Schiff D. et al. Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors. Crit. Care Med. 2005;33(7):1565– 1571. DOI: 10.1097/01.CCM.0000171207.95319.B2.Zhang Ch., Zhang Z., Mi J., Wang X., Zou Y., Chen X. et al. The cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxis. Medicine (Baltimore). 2019;98(23):e15833. DOI: 10.1097/MD.0000000000015833.Hunt B.J. Preventing Venous Thromboembolism in the Critically Ill — Can We do More? J. Intensive Care Soc. 2014;5(3):3–5. DOI: 10.1177/17511437140151S302.Tang N., Li D., Wang X., Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J. Thromb. Haemost. 2020;18(04):844–847. DOI: 10.1111/jth.14768.Zhang Ch., Zhang Z., Mi J., Wang X., Zou Y., Chen X. et al. The cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxis. Medicine (Baltimore). 2019;98(23):e15833. DOI: 10.1097/MD.0000000000015833.Panigada M., Bottino N., Tagliabue P., Grasselli G., Novembrino C., Chantarangkul V. et al. Hypercoagulability of COVID-19 patients in Intensive Care Unit. A Report of Thromboelastography Findings and other Parameters of Hemostasis. J. Thromb. Haemost. 2020;18(7):1738–1742. DOI: 10.1111/jth.14850.Tang N., Li D., Wang X., Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J. Thromb. Haemost. 2020;18(04):844–847. DOI: 10.1111/jth.14768.Azouz E., Yang S., Monnier-Cholley L., Arrivé L. Systemic arterial thrombosis and acute mesenteric ischemia in a patient with COVID-19. Intensive Care Med. 2020;46:1464–1465. DOI: 10.1007/s00134-020-06079-2.Panigada M., Bottino N., Tagliabue P., Grasselli G., Novembrino C., Chantarangkul V. et al. Hypercoagulability of COVID-19 patients in Intensive Care Unit. A Report of Thromboelastography Findings and other Parameters of Hemostasis. J. Thromb. Haemost. 2020;18(7):1738–1742. DOI: 10.1111/jth.14850.Bellosta R., Luzzani L., Natalini G., Bellosta R., Luzzani L., Natalini G. et al. Acute limb ischemia in patients with COVID-19 pneumonia. J. Vasc. Surg. 2020;S0741–5214(20)31080-6. DOI: 10.1016/j.jvs.2020.04.483.Azouz E., Yang S., Monnier-Cholley L., Arrivé L. Systemic arterial thrombosis and acute mesenteric ischemia in a patient with COVID-19. Intensive Care Medicine. 2020;46:1464–1465. DOI: 10.1007/s00134-020-06079-2.Ueki Y., Otsuka T., Windecker S., Räber L. ST-elevation myocardial infarction and pulmonary embolism in a patient with COVID-19 acute respiratory distress syndrome. Eur. Heart. J. 2020;41(22):2134. DOI: 10.1093/eurheartj/ehaa399ehaa399.Bellosta R., Luzzani L., Natalini G., Bellosta R., Luzzani L., Natalini G. et al. Acute limb ischemia in patients with COVID-19 pneumonia. J. Vasc. Surg. 2020;S0741–5214(20)31080-6. DOI: 10.1016/j.jvs.2020.04.483.Stefanini G.G., Montorfano M., Trabattoni D., Andreini D., Ferrante G., Ancona M. et al. ST-Elevation Myocardial Infarction in Patients With COVID-19: Clinical and Angiographic Outcomes Circulation. Circulation. 2020;141(25):2113–2116. DOI: 10.1161/CIRCULATIONAHA.120.047525.Ueki Y., Otsuka T., Windecker S., Räber L. ST-elevation myocardial infarction and pulmonary embolism in a patient with COVID-19 acute respiratory distress syndrome. Eur. Heart. J. 2020;41(22):2134. DOI: 10.1093/eurheartj/ehaa399ehaa399.Yaghi S, Ishida K, Torres J, Grory B.M., Raz E., Humbert K. et al. SARS2-CoV-2 and Stroke in a New York Healthcare System. Stroke. Originally published 20 May 2020 [Epub ahead of print]. DOI: 10.1161/STROKEAHA.120.030335.Stefanini G.G., Montorfano M., Trabattoni D., Andreini D., Ferrante G., Ancona M. et al. ST-Elevation Myocardial Infarction in Patients With COVID-19: Clinical and Angiographic Outcomes Circulation. Circulation. 2020;141(25):2113–2116. DOI: 10.1161/CIRCULATIONAHA.120.047525.Kwaan H.C. Coronavirus Disease 2019: The Role of the Fibrinolytic System from Transmission to Organ Injury and Sequelae. Seminars in thrombosis and hemostasis. [Epub ahead of print]. DOI: 10.1055/s-0040-1709996.Yaghi S, Ishida K, Torres J, Grory B.M., Raz E., Humbert K. et al. SARS2-CoV-2 and Stroke in a New York Healthcare System. Stroke. Originally published 20 May 2020 [Epub ahead of print]. DOI: 10.1161/STROKEAHA.120.030335.Brown N.J, Kim K.S, Chen Y.Q., Blevins L.S., Nadeau J.H., Meranze S.G., Vaughan D.E. et al. Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production. J. Clin. Endocrinol. Metab. 2000;85(01):336–344. DOI: 10.1210/jcem.85.1.6305.Kwaan H.C. Coronavirus Disease 2019: The Role of the Fibrinolytic System from Transmission to Organ Injury and Sequelae. Seminars in thrombosis and hemostasis. [Epub ahead of print]. DOI: 10.1055/s-0040-1709996.Vaduganathan M., Vardeny O., Michel T., McMurray J.J.V., Pfeffer M.A, Solomon S.D. et al. Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19. N. Engl. J. Med. 2020;382:1653– 1659. DOI: 10.1056/NEJMsr2005760.Brown N.J, Kim K.S, Chen Y.Q., Blevins L.S., Nadeau J.H., Meranze S.G., Vaughan D.E. et al. Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production. J. Clin. Endocrinol. Metab. 2000;85(01):336–344. DOI: 10.1210/jcem.85.1.6305.Zhou F., Yu T., Du R., Ting Yu., Du R., Fan G., Ying Liu, Liu Z. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. DOI: 10.1016/S01406736(20)30566-3.Vaduganathan M., Vardeny O., Michel T., McMurray J.J.V., Pfeffer M.A, Solomon S.D. et al. Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19. N. Engl. J. Med. 2020;382:1653– 1659. DOI: 10.1056/NEJMsr2005760.Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. DOI: 10.1016/S01406736(20)30183-5.Zhou F., Yu T., Du R., Ting Yu., Du R., Fan G., Ying Liu, Liu Z. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. DOI: 10.1016/S01406736(20)30566-3.Harzallah I., Debliquis A., Drenou B. Lupus anticoagulant is frequent in patients with Covid-19. J. Thromb. Haemost. 2020. [Epub ahead of print]. DOI: 10.1111/jth.14867.Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. DOI: 10.1016/S01406736(20)30183-5.Tichelaar V., Mulder A., Kluin-Nelemans H., Meijer K. The acute phase reaction explains only a part of initially elevated factor VIII: C levels: a prospective cohort study bin patient with venous thrombosis. Thromb. Res. 2012;129:183–186. DOI: 10.1016/j.thromres.2011.09.024.Harzallah I., Debliquis A., Drenou B. Lupus anticoagulant is frequent in patients with Covid-19. J. Thromb. Haemost. 2020. [Epub ahead of print]. DOI: 10.1111/jth.14867.Hantgan R.R., Simpson-Haidaris P.J., Francis C.W., Marder V.J. Fibrinogen structure and physiology. In: Hemostasis and Thrombosis: Basic Principles and Clinical Practice (ed. by R.W. Colman, Hirsh, V.J. Marder, A.W. Clowes & J.N. George), Lippincott Williams and Wilkins, Philadelphia, PA 2001:203–232.Tichelaar V., Mulder A., Kluin-Nelemans H., Meijer K. The acute phase reaction explains only a part of initially elevated factor VIII: C levels: a prospective cohort study bin patient with venous thrombosis. Thromb. Res. 2012;129:183–186. DOI: 10.1016/j.thromres.2011.09.024.Taylor F.B., Toh C.H. Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society of Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascularcoagulation. Thromb. Haemost. 2001;86:1327–1330.Hantgan R.R., Simpson-Haidaris P.J., Francis C.W., Marder V.J. Fibrinogen structure and physiology. In: Hemostasis and Thrombosis: Basic Principles and Clinical Practice (ed. by R.W. Colman, J. Hirsh, V.J. Marder, A.W. Clowes & J.N. George), Lippincott Williams and Wilkins, Philadelphia, PA 2001:203–232.Kumar A., Arora A., Sharma P., Anikhindi S.A., Bansal N., Singla V. et al. Clinical features of COVID-19 and factors associated with severe clinical course: a systematic review and meta-analysis. MedRx-iv. 2020. [Epub ahead of print]. DOI: 10.2139/ssrn.3566166.Taylor F.B., Toh C.H. Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society of Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascularcoagulation. Thromb. Haemost. 2001;86:1327–1330.Ma C., Gu J., Hou P., Ma C., Gu J., Hou P. et al. Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis. MedRxiv. 2020. [Epub ahead of print]. DOI: 10.1101/2020.03.17.20037572.Kumar A., Arora A., Sharma P., Anikhindi S.A., Bansal N., Singla V. et al. Clinical features of COVID-19 and factors associated with severe clinical course: a systematic review and meta-analysis. МedRxiv. 2020. [Epub ahead of print]. DOI: 10.2139/ssrn.3566166.Sadosty A.T, Goyal D.G., Boie E.T., Chiu C.K. Emergency department D-dimer testing. J. Emergency Med. 2001;21(4):423–429.Ma C., Gu J., Hou P., Ma C., Gu J., Hou P. et al. Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis. MedRxiv. 2020. [Epub ahead of print]. DOI: 10.1101/2020.03.17.20037572.Yin S., Huang M., Li D., Tang N. Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARSCoV-2. J. Thromb. Thrombolysis. 2020 Apr;3:1–4. [Epub ahead of print]. DOI: 10.1007/s11239-020-02105-8.Sadosty A.T, Goyal D.G., Boie E.T., Chiu C.K. Emergency department D-dimer testing. J. Emergency Med. 2001;21(4):423–429.Konstantinides S.V., Meyer G., Becattini C., Bueno H., Geersing G-J., Harjola V-P. et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur. Heart J. 2020;41(4):543–603. DOI: doi.org/10.1093/eurheartj/ehz405Yin S., Huang M., Li D., Tang N. Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARSCoV-2. J. Thromb. Thrombolysis. 2020 Apr;3:1–4. [Epub ahead of print]. DOI: 10.1007/s11239-020-02105-8.Stoneham S.M., Milne K.M., Nuttal E., Frew G.H, Sturrock B., Sivaloganathan H. et al. Thrombotic risk in COVID-19: a case series and case–control study. Clin. Med. 2020. [Epub ahead of print]. DOI: https://doi.org/10.7861/clinmed.2020-0228.Konstantinides S.V., Meyer G., Becattini C., Bueno H., Geersing G-J., Harjola V-P. et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur. Heart J. 2020;41(4):543–603. DOI: 10.1093/eurheartj/ehz405Yang X., Yang Q., Wang Y., Wu Y., Xu J., Yu Y. et al. Thrombocytopenia and its association with mortality in patients with COVID-19. J. Thromb. Haemost. 2020;18(6):1469–1472. [Epub ahead of print]. DOI: 10.1111/jth.14848.Stoneham S.M., Milne K.M., Nuttal E., Frew G.H, Sturrock B., Sivaloganathan H. et al. Thrombotic risk in COVID-19: a case series and case–control study. Clin. Med. 2020. [Epub ahead of print]. DOI: 10.7861/clinmed.2020-0228.Lippi G., Plebani M., Henry M.B. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin. Chim. Acta. 2020;506:145–148. DOI: 10.1016/j.cca.2020.03.022.Yang X., Yang Q., Wang Y., Wu Y., Xu J., Yu Y. et al. Thrombocytopenia and its association with mortality in patients with COVID-19. J. Thromb. Haemost. 2020;18(6):1469–1472. [Epub ahead of print]. DOI: 10.1111/jth.14848.Tang N, Bai H, Chen X, Gong J., Li D., Sun Z. et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J. Thromb. Haemost. 2020;18(05):1094–1099. DOI: 10.1111/jth.14817.Lippi G., Plebani M., Henry M.B. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin. Chim. Acta. 2020;506:145–148. DOI: 10.1016/j.cca.2020.03.022.Yang X., Shang Y. Response to «What do monitoring platelet counts in COVID-19 teach us?». J. Thromb. Haemost. 2020;18(8):2073. Online ahead of print. DOI: 10.1111/jth.14889.Tang N, Bai H, Chen X, Gong J., Li D., Sun Z. et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J. Thromb. Haemost. 2020;18(05):1094–1099. DOI: 10.1111/jth.14817.Manne BK, Xiang SC, Rondina MT. Platelet secretion in inflammatory and infectious diseases. Platelets. 2017;28(2):155–164. DOI: 10.1080/09537104.2016.1240766Yang X., Shang Y. Response to «What do monitoring platelet counts in COVID-19 teach us?». J. Thromb. Haemost. 2020;18(8):2073. Online ahead of print. DOI: 10.1111/jth.14889.Stockschlaeder M., Schneppenheim R., Budde U. Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis. Blood Coagul. Fibrinolysis. 2014;25(03):206–216. DOI: 10.1097/MBC.0000000000000065.McGonagle D., Sharif K., O’Regan A., Bridgewood C. The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun. Rev. 2020;19(6):102537. DOI: 10.1016/j.autrev.2020.102537.Fogarty H, Townsend L, Ni Cheallaigh C, Bergin C., Martin-Loeches I., Browne P. et al. COVID-19 Coagulopathy in Caucasian patients. Brit. J. Haematol. 2020;189:1044–1049. DOI: /10.1111/bjh.16749.Stockschlaeder M., Schneppenheim R., Budde U. Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis. Blood Coagul. Fibrinolysis. 2014;25(03):206–216. DOI: 10.1097/MBC.0000000000000065.Joob B., Wantwit V. Hemorrhagic Problem Among the Patients With COVID-19: Clinical Summary of 41 Thai Infected Patients. Clinical and Applied Thrombosis/Hemostasis. 2020Jan-Dec;26. [Epub ahead of print]. DOI: 10.1177/1076029620918308.Fogarty H, Townsend L, Ni Cheallaigh C, Bergin C., Martin-Loeches I., Browne P. et al. COVID-19 Coagulopathy in Caucasian patients. British J. Haematol. 2020;189:1044–1049. DOI: 10.1111/bjh.16749.Мачабели М.С. Тромбогеморрагический синдром. Пробл. гематол. 1981;1:48–54.Joob B., Wantwit V. Hemorrhagic Problem Among the Patients With COVID-19: Clinical Summary of 41 Thai Infected Patients. Clinical and Applied Thrombosis/Hemostasis. 2020Jan-Dec;26. [Epub ahead of print]. DOI: 10.1177/1076029620918308.Sharifi-Razavi A., Karimi N., Rouhani N. COVID-19 and intracerebral haemorrhage: causative or coincidental? New Microbes New Infect. 2020;35:100669. [Epub ahead of print]. DOI: 10.1016/j.nmni.2020.100669.Machabeli M. S. Thrombohemorrhagic syndrome. Probltmy hematologii. 1981;1:48–54. (in Russian).Xiao F, Tang M, Zheng X, Liu Y., Li X., Shan H. et al. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020;158(06):1831.e3–1833.e3. [Epub ahead of print]. DOI: 10.1053/j.gastro.2020.02.055.Sharifi-Razavi A., Karimi N., Rouhani N. COVID-19 and intracerebral haemorrhage: causative or coincidental? New Microbes New Infect. 2020;35:100669. [Epub ahead of print]. DOI: 10.1016/j.nmni.2020.100669.Iba T., Nisio M.D., Levy J.H., et al. New criteria for sepsis — induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey. BMJ Open. 2017;7:e017046. DOI: 10.1136/bmjopen-2017-017046.Xiao F, Tang M, Zheng X, Liu Y., Li X., Shan H. et al. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020;158(06):1831.e3–1833.e3. [Epub ahead of print]. DOI: 10.1053/j.gastro.2020.02.055.Iba T., Levy J.H., Yamakawa K., Kitamura N., Thachil J. Scientific and Standardization Committee on DIC of the International Society on Thrombosis and Haemostasis. Proposal of a two-step process for the diagnosis of sepsis-induced disseminated intravascular coagulation. J. Thromb. Haemost. 2019;17(8):1265–1268. DOI: 10.1111/jth.14578.Iba T., Nisio M.D., Levy J.H., et al. New criteria for sepsis — induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey. BMJ Open. 2017;7:e017046. DOI: 10.1136/bmjopen-2017-017046.Bokarev I.N., Popova L.V. Detection of disseminated intravascular coagulation with the help of the conception of constant intravascular microcoagulation. Srp. Arh. Celok. Lek. 2010;138(1):53–58. DOI: 10,2298/sarh10s1053b.Iba T., Levy J.H., Yamakawa K., Kitamura N., Thachil J. Scientific and Standardization Committee on DIC of the International Society on Thrombosis and Haemostasis. Proposal of a two-step process for the diagnosis of sepsis-induced disseminated intravascular coagulation. J. Thromb. Haemost. 2019;17(8):1265–1268. DOI: 10.1111/jth.14578.Бокарев И.Н., Попова Л.В., Савин А.А. ДВС-синдром и постоянное внутрисосудистое микросвертывание крови. Москва .2016.Bokarev I, Popova LV. Detection of disseminated intravascular coagulation with the help of the conception of constant intravascular microcoagulation. Srp. Arh. Celok. Lek. 2010;138(1):53–58. DOI: 10,2298/sarh10s1053b.Бокарев И.Н, Щепотин Б.М.,. Ена Я.М. Внутрисосудистое свертывание крови Киев : Здоровья, 1989. С. 237Bokarev I.N., Popova L.V., Savin A.A DIC and Constant Intravascular Microcoagulation of Blood. Moscow. 2016. (in Russian).Великов В.К. Хроническое внутрисосудистое микросвертывание крови и диабетическая микроангиопатия. Терапевтический архив. 1989;5:26.Bokarev I. N, Schepotin B. M.,. Ena Ya.M. Intravascular blood coagulation Kiev: Health, 1989. p. 237. (in Russian).Marietta M., Ageno W., Artoni A., De Candia E., Gresele P., Marchetti M., et al. COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET). Blood Transfus. 2020;18(03):167–169. DOI: 10.2450/2020.0083-20.Velikov VK, Chronic intravascular blood microcoagulation and diabetic microangiopathy. Therapeutic archive. 1989;5:26. (in Russian).Oudkerk M., Buller H.R., Kuijpers D., van Es N., Oudkerk S.F., McLoud T.C., et al. Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands. Radiology. 2020:201629. DOI: 10.1148/radiol.2020201629.Marietta M., Ageno W., Artoni A., De Candia E., Gresele P., Marchetti M., et al. COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET). Blood Transfus. 2020;18(03):167–169. DOI: 10.2450/2020.0083-20.Временные методические рекомендации. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). 2020; Версия 6 (28.04.2020).Oudkerk M., Buller H.R., Kuijpers D., van Es N., Oudkerk S.F., McLoud T.C., et al. Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands. Radiology. 2020:201629. DOI: 10.1148/radiol.2020201629.Spyropoulos A.C., Levy J.H., Ageno W., Connors J.M., Hunt B.J., Iba T. et al. Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID-19. J. Thromb. Haemost. 2020;18(8):1859–1865. DOI: 10.1111/jth.14929. doi: 10.1111/jth.14929The provisional guidelines. Prevention, diagnosis and treatment of new coronavirus infection (COVID-19). 2020; Ver. 6 (28.04.2020). (in Russian).Moores L.K., Tritschler T., i Brosnahan S., Carrier M., Collen J.F., Doerschug K., et al. Prevention, Diagnosis and Treatment of VTE in Patients With COVID-19 CHEST Guideline and Expert Panel Report Chest. 2020. [Epub ahead of print] DOI: 10.1016/j.chest.2020.05.559.Spyropoulos A.C., Levy J.H., Ageno W., Connors J. M., Hunt B.J. Iba T. et al. Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID-19. J. Thromb. Haemost. 2020;18(8):1859–1865. DOI: 10.1111/jth.14929.Moores L.K., Tritschler T., i Brosnahan S., Carrier M., Collen J.F., Doerschug K., et al. Prevention, Diagnosis and Treatment of VTE in Patients With COVID-19 CHEST Guideline and Expert Panel Report Chest. 2020. [Epub ahead of print] DOI: 10.1016/j.chest.2020.05.559.Moores L.K., Tritschler T., i Brosnahan S., Carrier M., Collen J.F., Doerschug K., et al. Prevention, Diagnosis and Treatment of VTE in Patients With COVID-19 CHEST Guideline and Expert Panel Report Chest. 2020. [Epub ahead of print] DOI: 10.1016/j.chest.2020.05.559.

The authors declare that there are no conflicts of interest present.